|
|
|
Home > Resource Finder > Centre > Research Areas
|
|
|
|
|
|
|
|
|
Research areas
Research in the following areas of health or disease is currently taking place within the Richmond Pharmacology:
- Blood
- Cancer
- Cardiovascular
- Congenital Disorders
- Eye
- Infection
- Inflammatory and Immune System
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal
- Neurological
- Oral and Gastrointestinal
- Renal and Urogenital
- Reproductive Health and Childbirth
- Respiratory
- Generic Health Relevance
Click here
for clarification of the conditions included within these categories.
The following types of clinical research can be undertaken within the Richmond Pharmacology:
- Experimental medicine
- Phase I
- First-in-man
- Pharmacokinetic studies
- Pharmacodynamic studies
- Phase II
- Phase III
- Other
- Early dose escalation studies
- Paediatric studies
- Ethnic comparison studies
Both clinical units within Richmond Pharmacology have achieved MHRA Phase I Standard and Supplementary Accreditation i.e. they are accredited to conduct all types of Phase I studies including those studies testing potentially higher risk compounds that required review by the Expert Advisory Group in addition to the standard MHRA Clinical Trial Authorisation.
|
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
|